We are live on ! Find out more
Loomis, Sayles & Company

Loomis, Sayles & Company Portfolio holdings

AUM $74.3B
1-Year Est. Return 24.01%
This Fund
S&P 500
This Quarter Est. Return
+5.89%
1 Year Est. Return
+24.01%
3 Year Est. Return
+109.67%
5 Year Est. Return
+145.58%
10 Year Est. Return
+623.12%
AUM
$53.6B
AUM Growth
+$2.66B
Cap. Flow
+$86.8M
Cap. Flow %
0.16%
Top 10 Hldgs %
37.17%
Holding
821
New
56
Increased
227
Reduced
258
Closed
253

Top Buys

Rank Stock Value
1
BMY icon
Bristol-Myers Squibb
BMY
+$86.2M
2
ALC icon
Alcon
ALC
+$81.8M
3
NVDA icon
NVIDIA
NVDA
+$76M
4
GLW icon
Corning
GLW
+$50.4M
5
UNH icon
UnitedHealth
UNH
+$42.3M

Top Sells

Rank Stock Value
1
NVS icon
Novartis
NVS
+$67.4M
2
FDS icon
Factset
FDS
+$62M
3
EEFT icon
Euronet Worldwide
EEFT
+$42.3M
4
BAC.PRL icon
Bank of America Series L
BAC.PRL
+$39.5M
5
OPLN
Openlane
OPLN
+$31.3M

Sector Composition

Rank Sector Weight
1 Technology 20.75%
2 Consumer Discretionary 17.74%
3 Financials 11.65%
4 Healthcare 11.2%
5 Communication Services 10.97%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
TOWR
776
DELISTED
Tower International, Inc.
TOWR
-296
Closed -$6K
CHSP
777
DELISTED
Chesapeake Lodging Trust
CHSP
-573
Closed -$16K
APC
778
DELISTED
Anadarko Petroleum
APC
-9,007
Closed -$410K
HK.WS
779
DELISTED
Halcon Resources Corporation
HK.WS
$0 ﹤0.01%
98,612
BRSS
780
DELISTED
Global Brass & Copper Hldgs, Inc
BRSS
-784
Closed -$27K
ULTI
781
DELISTED
Ultimate Software Group Inc
ULTI
-58,155
Closed -$19.2M
FBC
782
DELISTED
Flagstar Bancorp, Inc. New
FBC
-763
Closed -$25K
HIBB
783
DELISTED
Hibbett, Inc. Common Stock
HIBB
-630
Closed -$14K
EE
784
DELISTED
El Paso Electric Company
EE
-432
Closed -$25K
BHVN
785
DELISTED
Biohaven Pharmaceutical Holding Company Ltd.
BHVN
-361,363
Closed -$18.6M
GCI
786
DELISTED
Gannett Co., Inc
GCI
-2,051
Closed -$22K

Similar funds

Loomis, Sayles & Company's Q2 2019 Portfolio in Review

As of Q2 2019, Loomis, Sayles & Company held 821 positions worth $53.6B, up 5.2% from $50.9B the previous quarter. Its ten largest holdings account for 37% of the portfolio.

Loomis, Sayles & Company's Q2 2019 filing shows 56 new, 227 increased, 258 reduced and 253 closed positions. Its largest new stake was Alcon: 1,393,674 shares worth $86.5M. The largest sale was Novartis, an estimated $67.4M.

By sector, the portfolio is most concentrated in Technology at 21% of assets, up from 20% a quarter earlier, followed by Consumer Discretionary and Financials.

  • Loomis, Sayles & Company's largest Q2 2019 buy was Alcon: 1,393,674 shares worth $86.5M.
  • Loomis, Sayles & Company added most to Bristol-Myers Squibb in Q2 2019, an estimated $86.2M increase.
  • Loomis, Sayles & Company's biggest Q2 2019 reduction was Novartis, cutting an estimated $67.4M.
  • Loomis, Sayles & Company fully exited RingCentral in Q2 2019, selling an estimated $30.4M.
  • Loomis, Sayles & Company's ten largest holdings make up 37% of its $53.6B portfolio in Q2 2019.
  • Loomis, Sayles & Company opened 56 new positions and closed 253 in Q2 2019.
  • Loomis, Sayles & Company's portfolio value rose 5.2% quarter-over-quarter to $53.6B.

Based on Loomis, Sayles & Company's 13F filing for Q2 2019, filed 14 Aug 2019.